About Phase 3 Trials
Phase 3 trials compare the new treatment against existing treatments in large groups. They're the final step before FDA approval. Compensation: $100–$2,000.
Compensation: $100–$2,000
Compensation for Phase 3 trials varies by study length, visit frequency, and procedures involved. Inpatient studies that require overnight stays pay significantly more than outpatient visits.
Browse by Condition
All Trial Phases
Find Trials by City
Learn More
Frequently Asked Questions
How much do Phase 3 clinical trials pay?
Phase 3 trials typically pay $100–$2,000. Compensation depends on the study duration, number of visits, and whether overnight stays are required.
Who can join Phase 3 trials?
Phase 3 trials recruit patients with the specific condition being studied. Check each trial's eligibility criteria for details.